Covered recipient · General Payments record
KRISTI BURKHART
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$565.51
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $285.02 | 21 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $153.70 | 20 |
| Acerta Pharma LLC | $131.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (21)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $7.88 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117213984 | CMS |
| Amgen Inc. | $6.79 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117213986 | CMS |
| Amgen Inc. | $7.52 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117213988 | CMS |
| Amgen Inc. | $7.08 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117213990 | CMS |
| Amgen Inc. | $11.06 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117213992 | CMS |
| Amgen Inc. | $8.76 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117213994 | CMS |
| Amgen Inc. | $7.46 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117213996 | CMS |
| Amgen Inc. | $7.47 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117213998 | CMS |
| Amgen Inc. | $8.67 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117214000 | CMS |
| Amgen Inc. | $5.84 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117214002 | CMS |
| Amgen Inc. | $7.88 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117214004 | CMS |
| Amgen Inc. | $8.05 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117214006 | CMS |
| Amgen Inc. | $9.25 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117214008 | CMS |
| Amgen Inc. | $8.48 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117214010 | CMS |
| Amgen Inc. | $7.42 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117214012 | CMS |
| Amgen Inc. | $6.13 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117214014 | CMS |
| Amgen Inc. | $6.96 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117214016 | CMS |
| Amgen Inc. | $7.23 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117214018 | CMS |
| Amgen Inc. | $6.83 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117214020 | CMS |
| Amgen Inc. | $6.94 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117214022 | CMS |
| AstraZeneca Pharmaceuticals LP | $131.32 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104687930 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.